Lexicon Pharmaceuticals Stock Target Price and Analyst Consensus

LXRX Stock  USD 2.46  0.27  12.33%   
The current analyst and expert consensus on Lexicon Pharmaceuticals is Buy, with 1 strong buy opinions. The current projected Lexicon Pharmaceuticals target price consensus is 5.55 with 4 analyst opinions. The most common way Lexicon Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Lexicon Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Lexicon Pharmaceuticals. We encourage you to use your own analysis of Lexicon Pharmaceuticals to validate this buy or sell advice. Lexicon Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Lexicon Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Lexicon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.
Lowest Forecast
5.05
Highest Forecast
6.16
Target Price
5.55
Gross Profit Margin is likely to rise to 0.98 in 2024, whereas Gross Profit is likely to drop slightly above 1.1 M in 2024. At this time, Lexicon Pharmaceuticals' Total Liabilities is fairly stable compared to the past year. Total Current Assets is likely to rise to about 221.8 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 75.1 M in 2024.
  
It's important to approach Lexicon Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Lexicon Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lexicon target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Lexicon Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   4  Buy
Most Lexicon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Lexicon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Lexicon Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Lexicon Pharmaceuticals Target Price Projection

Lexicon Pharmaceuticals' current and average target prices are 2.46 and 5.55, respectively. The current price of Lexicon Pharmaceuticals is the price at which Lexicon Pharmaceuticals is currently trading. On the other hand, Lexicon Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Lexicon Pharmaceuticals Market Quote on 28th of March 2024

Low Price2.2Odds
High Price2.46Odds

2.46

Target Price

Analyst Consensus On Lexicon Pharmaceuticals Target Price

Low Estimate5.05Odds
High Estimate6.16Odds

5.55

Historical Lowest Forecast  5.05 Target Price  5.55 Highest Forecast  6.16
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Lexicon Pharmaceuticals and the information provided on this page.

Lexicon Pharmaceuticals Analyst Ratings

Lexicon Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Lexicon Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Lexicon Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Lexicon Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Lexicon Pharmaceuticals price targets

Lexicon Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Lexicon Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Lexicon Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Lexicon Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Lexicon Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Lexicon Pharmaceuticals is a key component of Lexicon Pharmaceuticals valuation and have some predictive power on the future returns of a Lexicon Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexicon Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.112.1910.00
Details
Intrinsic
Valuation
LowRealHigh
0.101.949.75
Details
Naive
Forecast
LowNextHigh
0.052.2810.09
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.2-0.2-0.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lexicon Pharmaceuticals. Your research has to be compared to or analyzed against Lexicon Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Lexicon Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lexicon Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Lexicon Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lexicon Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lexicon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lexicon Pharmaceuticals Stock:
Check out Macroaxis Advice on Lexicon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Lexicon Stock analysis

When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
The data published in Lexicon Pharmaceuticals' official financial statements usually reflect Lexicon Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lexicon Pharmaceuticals. For example, before you start analyzing numbers published by Lexicon accountants, it's critical to develop an understanding of what Lexicon Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Lexicon Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lexicon Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lexicon Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lexicon Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Lexicon Pharmaceuticals' management manipulating its earnings.